Gary A Weisman Selected Research

Gliosis

1/2019	Purinergic signaling in Alzheimer's disease.
1/2005	Molecular determinants of P2Y2 nucleotide receptor function: implications for proliferative and inflammatory pathways in astrocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gary A Weisman Research Topics

Disease

13	Inflammation (Inflammations) 01/2022 - 01/2005
12	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 10/2002
11	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 05/2005
10	Astrocytoma (Pilocytic Astrocytoma) 06/2009 - 02/2003
8	Atherosclerosis 01/2009 - 11/2002
6	Neoplasms (Cancer) 08/2023 - 01/2019
6	Hyperplasia 01/2016 - 11/2002
4	Menkes Kinky Hair Syndrome (Menkes Disease) 11/2015 - 01/2012
3	Head and Neck Neoplasms (Head and Neck Cancer) 05/2024 - 01/2019
3	Sialadenitis 04/2021 - 10/2012
3	Carcinogenesis 01/2021 - 01/2019
3	Xerostomia 12/2020 - 01/2019
2	Fibrosis (Cirrhosis) 05/2024 - 01/2015
2	Mouth Neoplasms (Oral Cancer) 08/2023 - 06/2020
2	Squamous Cell Carcinoma of Head and Neck 08/2023 - 06/2020
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2019
2	Disease Progression 01/2019 - 06/2013
2	Gliosis 01/2019 - 01/2005
2	Wounds and Injuries (Trauma) 01/2017 - 10/2004
2	Seizures (Absence Seizure) 11/2015 - 06/2015
2	Spinal Muscular Atrophies of Childhood (Werdnig Hoffman Disease) 06/2015 - 01/2012
2	Neuroinflammatory Diseases 01/2015 - 08/2012
2	Type 2 Diabetes Mellitus (MODY) 06/2014 - 09/2012
2	Mitochondrial Diseases (Mitochondrial Disease) 02/2011 - 10/2005
2	Amyloid Plaque 09/2010 - 05/2005
2	Brain Injuries (Brain Injury) 11/2005 - 01/2005
2	Vascular System Injuries 07/2003 - 11/2002
1	Immunoglobulin G4-Related Disease 05/2024
1	Osteoporosis 01/2023
1	Dacryocystitis (Dacryoadenitis) 01/2022
1	Thrombosis (Thrombus) 01/2021
1	Mucositis 12/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Dental Caries (Decay, Dental) 01/2020
1	Ageusia (Hypogeusia) 01/2020
1	Periodontitis 01/2020
1	Carcinoma (Carcinomatosis) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Salmonella Infections (Salmonellosis) 01/2017
1	Infections 01/2017
1	Thyroid Diseases (Thyroid Disease) 01/2016
1	Demyelinating Diseases (Demyelinating Disease) 11/2015
1	Intellectual Disability (Idiocy) 11/2015
1	Ataxia (Dyssynergia) 11/2015
1	Muscular Atrophy (Muscle Atrophy) 06/2015
1	Muscle Hypotonia (Hypotonia) 06/2015
1	Failure to Thrive 06/2015

Drug/Important Bio-Agent (IBA)

22	NucleotidesIBA 08/2023 - 11/2002
11	Purinergic P2Y2 ReceptorsIBA 08/2023 - 11/2002
8	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2005
7	Purinergic Receptors (Receptors, Purine)IBA 08/2023 - 06/2005
7	GTP-Binding Proteins (G-Protein)IBA 04/2021 - 05/2005
7	Amyloid (Amyloid Fibrils)IBA 01/2019 - 05/2005
7	CopperIBA 01/2019 - 09/2010
6	CytokinesIBA 01/2015 - 01/2005
5	Uridine Triphosphate (UTP)IBA 06/2020 - 11/2002
3	Indicators and Reagents (Reagents)IBA 06/2020 - 09/2006
3	Purinergic P2X7 ReceptorsIBA 01/2019 - 02/2003
3	Copper Transport ProteinsIBA 01/2017 - 01/2012
3	Amyloid beta-PeptidesIBA 03/2012 - 05/2005
3	Arachidonic Acid (Vitamin F)IBA 02/2011 - 10/2002
3	Messenger RNA (mRNA)IBA 10/2009 - 11/2002
2	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2024 - 01/2015
2	Adenosine Triphosphate (ATP)IBA 01/2019 - 02/2003
2	Ion Channels (Ion Channel)IBA 01/2019 - 02/2003
2	P-type ATPasesIBA 01/2017 - 09/2010
2	N-Methylaspartate (NMDA)IBA 11/2015 - 02/2011
2	Peptides (Polypeptides)IBA 02/2011 - 09/2010
2	Phospholipases A2 (Phospholipase A2)IBA 06/2010 - 01/2005
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 06/2009 - 05/2005
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2008 - 07/2003
2	UridineIBA 06/2005 - 11/2002
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2005 - 11/2002
1	Extracellular Matrix ProteinsIBA 05/2024
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023
1	resolvin D1IBA 01/2023
1	Phenolsulfonphthalein (Phenol Red)IBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	NucleosidesIBA 01/2021
1	Mitogen-Activated Protein KinasesIBA 01/2021
1	src-Family KinasesIBA 01/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2020
1	Fura-2 (Fura 2)IBA 06/2020
1	AR-C118925IBA 06/2020
1	ErbB Receptors (EGF Receptor)IBA 06/2020
1	AlarminsIBA 01/2020
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2019
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2019
1	EnzymesIBA 01/2019
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2019
1	CD40 Ligand (CD40L)IBA 01/2018
1	AutoantibodiesIBA 01/2018
1	Carbachol (Carbastat)FDA Link 10/2017
1	3- (5- (2,3- dichlorophenyl)- 1H- tetrazol- 1- yl)methylpyridineIBA 10/2017
1	Sodium IodideIBA 01/2016

Therapy/Procedure

5	Radiotherapy 05/2024 - 01/2019
1	Immunomodulation 01/2021
1	Therapeutics 06/2020
1	Denervation 06/2015
1	Ligation 01/2015